Lpath Temporarily Suspends Dosing of iSONEP in Clinical Trials Due to cGMP Compliance Issues at Contract Fill/Finish Source

Management to Host Investor Conference Call Tomorrow, Friday, January 27 at 8:45 a.m. ET

Marketwire – Surgery and Treatments

Speak Your Mind

*

Powered by Yahoo! Answers